How HIV/AIDS Affects the Eyes
HIV (human immunodeficiency virus) attacks the immune system, progressively reducing the body's ability to fight infections and certain cancers. As immune function declines — particularly when the CD4 cell count drops below critical levels — the eyes become increasingly vulnerable to a range of opportunistic infections, inflammatory conditions, and vascular changes that can threaten vision.
Approximately two-thirds of individuals living with HIV develop some form of ocular complication during the course of their disease. At West Boca Eye Center in Boca Raton, Dr. Brent Bellotte provides specialized monitoring and treatment of HIV-related eye conditions, working in coordination with each patient's infectious disease physician to protect both systemic health and vision.
Common Ocular Complications of HIV/AIDS
HIV can affect virtually every structure of the eye. The type and severity of ocular involvement typically correlate with the degree of immune suppression. The most clinically significant complications include:
HIV Retinopathy and Cotton-Wool Spots
The most common ocular finding in HIV-positive patients is HIV retinopathy — small areas of retinal damage caused by microvasculopathy (disease of the small blood vessels). Cotton-wool spots appear as white, fluffy patches on the retina and represent localized areas where retinal nerve fibers have lost their blood supply. HIV retinopathy is typically asymptomatic and does not usually cause vision loss, but it signals underlying vascular compromise and warrants ongoing monitoring.
Cytomegalovirus (CMV) Retinitis
CMV retinitis is the most sight-threatening ocular complication of AIDS and was historically the leading cause of blindness in AIDS patients before the introduction of antiretroviral therapy. CMV is a herpesvirus that is harmless in individuals with healthy immune systems but can cause devastating retinal destruction in immunocompromised patients, particularly those with CD4 counts below 50 cells per microliter. CMV retinitis causes progressive retinal necrosis — dead zones of retina that appear as white, cottage-cheese-like patches often accompanied by retinal hemorrhage. Without treatment, it leads to irreversible vision loss and retinal detachment.
Acute Retinal Necrosis (ARN) and Progressive Outer Retinal Necrosis (PORN)
These are aggressive viral retinal infections caused by herpes simplex or varicella-zoster viruses. ARN typically presents with pain, redness, and rapid vision loss. PORN, seen almost exclusively in severely immunocompromised patients, progresses even faster and can destroy retinal tissue within days. Both conditions require immediate antiviral treatment to limit retinal damage.
Kaposi Sarcoma
Kaposi sarcoma is a vascular tumor associated with human herpesvirus 8 (HHV-8) that can develop on the eyelids or conjunctiva in patients with AIDS. These lesions appear as reddish-purple, raised growths and may cause discomfort, tearing, or cosmetic concerns. Treatment options include local radiation, cryotherapy, surgical excision, or chemotherapy depending on size and location.
Herpes Zoster Ophthalmicus
Reactivation of the varicella-zoster virus (the virus that causes chickenpox) is more common and more severe in immunocompromised patients. When shingles affects the ophthalmic branch of the trigeminal nerve, it can cause corneal ulceration, anterior uveitis, secondary glaucoma, and scarring. Dr. Bellotte initiates antiviral treatment promptly to reduce the severity and duration of ocular involvement.
Other Ocular Manifestations
Additional eye conditions seen in HIV/AIDS patients include anterior uveitis (inflammation inside the eye), optic neuropathy, cranial nerve palsies causing double vision or eye movement abnormalities, and drug-related toxicity from certain antiretroviral or antimicrobial medications that can affect the retina or optic nerve. Immune recovery uveitis may also occur when patients begin effective antiretroviral therapy, causing paradoxical inflammation as the immune system recovers.
Symptoms of HIV-Related Eye Disease
Patients with HIV/AIDS should be alert to any changes in vision or eye comfort, including:
- Painless, progressive vision loss or blurred vision — may indicate CMV retinitis or retinal necrosis
- Floaters or flashing lights — may signal retinal inflammation, hemorrhage, or detachment
- Eye pain, redness, or light sensitivity — may indicate uveitis, herpes zoster, or acute retinal necrosis
- Reddish-purple growths on the eyelid or eye surface — may indicate Kaposi sarcoma
- Double vision or difficulty moving the eyes — may indicate cranial nerve involvement
- Fluid-filled blisters on the eyelids or surrounding skin — may indicate herpes zoster reactivation
Many HIV-related eye conditions are initially asymptomatic and can only be detected through dilated fundus examination. This is why regular ophthalmic screening is essential for all patients living with HIV, regardless of current CD4 count or viral load.
Diagnosis and Monitoring
At West Boca Eye Center, Dr. Bellotte performs comprehensive ophthalmic evaluations for HIV-positive patients that include:
- Dilated fundus examination: Direct visualization of the retina, optic nerve, and retinal blood vessels to identify cotton-wool spots, CMV retinitis, retinal necrosis, or hemorrhage
- Optical coherence tomography (OCT): High-resolution imaging to detect retinal thinning, macular edema, or subclinical changes not visible on clinical exam
- Slit-lamp examination: Evaluation of the cornea, anterior chamber, and lens for signs of uveitis, keratitis, or drug-related deposits
- External examination: Assessment of the eyelids, conjunctiva, and surrounding skin for Kaposi sarcoma lesions, herpes zoster, or other external manifestations
Screening frequency depends on CD4 count and overall immune status. Patients with CD4 counts below 200 should be examined every three to six months, and those below 50 may require monthly monitoring. West Boca Eye Center coordinates directly with each patient's infectious disease team to align ophthalmic care with systemic treatment decisions.
Treatment of HIV-Related Eye Conditions
Treatment depends on the specific ocular complication identified:
- CMV retinitis: Treated with antiviral medications (ganciclovir, valganciclovir, foscarnet, or cidofovir) administered systemically or through intravitreal injection directly into the eye. Maintenance therapy may be required until immune reconstitution occurs with effective antiretroviral treatment.
- Retinal necrosis (ARN/PORN): Requires urgent high-dose intravenous antiviral therapy, often combined with intravitreal injections. Surgical intervention may be necessary if retinal detachment develops.
- Herpes zoster ophthalmicus: Oral antiviral medications (valacyclovir, acyclovir) and topical steroids to reduce inflammation and prevent corneal scarring.
- Kaposi sarcoma: Treatment options include local radiation, cryotherapy, surgical excision, or systemic chemotherapy. Effective antiretroviral therapy often leads to regression of Kaposi sarcoma lesions.
- Uveitis: Topical or periocular corticosteroids to control inflammation, with close monitoring for secondary complications including elevated eye pressure.
The most important factor in preventing and managing HIV-related eye disease is effective antiretroviral therapy. Maintaining immune function through consistent HIV treatment dramatically reduces the risk of opportunistic eye infections.
Schedule an HIV Eye Health Evaluation
If you are living with HIV or AIDS and have not had a recent comprehensive eye examination, or if you are experiencing any changes in vision, schedule an evaluation at West Boca Eye Center. Dr. Bellotte provides expert screening and treatment of all HIV-related ocular conditions in coordination with your infectious disease care team.
West Boca Eye Center is located at 9325 Glades Road, Suite 200, Boca Raton, FL 33434. To schedule an appointment, call (561) 482-5502.
Frequently Asked Questions
How does HIV affect the eyes?
HIV weakens the immune system, making the eyes vulnerable to opportunistic infections, vascular damage, and inflammatory conditions. The most common finding is HIV retinopathy (cotton-wool spots on the retina), while the most serious threat is CMV retinitis, which can cause irreversible vision loss if untreated. Other complications include herpes-related eye infections, Kaposi sarcoma, uveitis, and cranial nerve palsies.
How often should HIV-positive patients have eye exams?
All patients diagnosed with HIV should have a baseline comprehensive eye examination. The recommended frequency of follow-up depends on immune status: patients with CD4 counts above 200 should be examined annually, those between 50 and 200 every three to six months, and those below 50 as frequently as monthly. Any new visual symptoms warrant immediate evaluation regardless of scheduled follow-up timing.
What is CMV retinitis?
Cytomegalovirus retinitis is a serious opportunistic infection that destroys retinal tissue in severely immunocompromised patients, particularly those with CD4 counts below 50. It was historically the leading cause of blindness in AIDS patients. CMV retinitis causes progressive white patches and hemorrhaging in the retina and can lead to retinal detachment. Treatment involves antiviral medications given systemically or by intravitreal injection.
Can HIV-related vision loss be reversed?
It depends on the condition and how early it is detected. Retinal tissue destroyed by CMV retinitis or retinal necrosis does not regenerate, making early detection critical. However, treatment can stop progression and preserve remaining vision. Some conditions, such as uveitis and herpes zoster keratitis, can be resolved with appropriate treatment. The most effective prevention is maintaining immune function through consistent antiretroviral therapy.
Does antiretroviral therapy reduce the risk of eye problems?
Yes, significantly. Effective antiretroviral therapy maintains immune function and dramatically reduces the incidence of opportunistic eye infections, including CMV retinitis. Since the introduction of modern antiretroviral regimens, the rate of CMV retinitis has declined substantially. However, patients starting antiretroviral therapy may occasionally develop immune recovery uveitis — a paradoxical inflammatory response as the immune system reconstitutes — which requires ophthalmic monitoring.
